Retraction: Lycorine displays potent antitumor efficacy in colon carcinoma by targeting STAT3
Saved in:
| Main Author: | Frontiers Editorial Office |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Pharmacology |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1596508/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retraction: Mir-124 attenuates STAT3-mediated TH17 differentiation in colitis-driven colon cancer
by: Frontiers Editorial Office
Published: (2024-10-01) -
Retraction: Eupalinolide J suppresses the growth of triple-negative breast cancer cells via targeting STAT3 signaling pathway
by: Frontiers Editorial Office
Published: (2025-06-01) -
Retraction: ErHuang formula improves renal fibrosis in diabetic nephropathy rats by inhibiting CXCL6/JAK/STAT3 signaling pathway
by: Frontiers Editorial Office
Published: (2024-12-01) -
Retraction: Corrigendum: ErHuang formula improves renal fibrosis in diabetic nephropathy rats by inhibiting CXCL6/JAK/STAT3 signaling pathway
by: Frontiers Editorial Office
Published: (2024-12-01) -
Lycorine hydrochloride directly targets UBA1 to suppress cellular senescence
by: Jiaqing Yang, et al.
Published: (2025-03-01)